Clinical Trial Update: Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of metronomic vinorelbine with bevacizumab in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED